Phase I/II study of low-dose intravenous OKT3 and subcutaneous interleukin-2 in metastatic cancer (Q72748740)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 January 1993
edit
Language Label Description Also known as
English
Phase I/II study of low-dose intravenous OKT3 and subcutaneous interleukin-2 in metastatic cancer
scientific article published on 01 January 1993

    Statements

    Phase I/II study of low-dose intravenous OKT3 and subcutaneous interleukin-2 in metastatic cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit